Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment
- 1 June 2007
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 73 (11) , 1703-1714
- https://doi.org/10.1016/j.bcp.2007.01.035
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Drug Insight: cancer cell immortality—telomerase as a target for novel cancer gene therapiesNature Clinical Practice Oncology, 2004
- Telomere maintenance in clinical medicineThe American Journal of Medicine, 2004
- Mammalian telomeres and telomerase: why they matter for cancer and agingEuropean Journal of Cell Biology, 2003
- Biochemical aspects of telomerase functionCancer Letters, 2003
- hTERT associates with human telomeres and enhances genomic stability and DNA repairOncogene, 2003
- TERT regulates cell survival independent of telomerase enzymatic activityOncogene, 2002
- Protection of mammalian telomeresOncogene, 2002
- Telomerase and differentiation in multicellular organisms: Turn it off, turn it on, and turn it off againDifferentiation, 2002
- Mammalian Telomeres End in a Large Duplex LoopCell, 1999
- A survey of telomerase activity in human cancerPublished by Elsevier ,1997